Reduced transcutaneous oxygen tension and impaired vascular response in type 1 (insulin-dependent) diabetes
- 1 October 1983
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 25 (4), 340-342
- https://doi.org/10.1007/bf00253198
Abstract
Measurements of transcutaneous oxygen tension were made on the foot and arm in 16 Type 1 (insulin-dependent) diabetic patients with no evidence of vascular or neurological disease on simple clinical examination and in 30 nondiabetic subjects. The mean transcutaneous oxygen tension measured at 45°C on the foot was significantly lower in the diabetic patients than in the non-diabetic subjects. The hyperaemic response in the arm after cuff occlusion (measured by transcutaneous oxygen tension at 37°C) was also significantly lower in the diabetic patients. These results may reflect abnormal capillary blood flow in diabetic patients. As the methods are simple and non-invasive, they may prove useful in the early assessment and subsequent monitoring of peripheral vascular problems in diabetes.This publication has 9 references indexed in Scilit:
- The diabetic legDiabetologia, 1982
- Blood flow in the diabetic neuropathic footDiabetologia, 1982
- Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting?Diabetologia, 1982
- EARLY REDUCTION OF VASCULAR REACTIVITY IN DIABETIC CHILDREN DETECTED BY TRANSCUTANEOUS OXYGEN ELECTRODEThe Lancet, 1981
- Transcutaneous oxygen tension measurements as a method of assessing peripheral vascular deceaseClinical Physics and Physiological Measurement, 1981
- Postischaemic hyperaemia studied with a transcutaneous oxygen electrode used at 33—37°CScandinavian Journal of Clinical and Laboratory Investigation, 1981
- TRANS-CUTANEOUS PO2 OF VOLUNTEERS DURING HYPERBARIC OXYGENATION1977
- Continuous Transcutaneous Oxygen Tension Measured with a Heated ElectrodeScandinavian Journal of Clinical and Laboratory Investigation, 1973
- IMPROVEMENT IN NERVE CONDUCTION FOLLOWING TREATMENT IN NEWLY DIAGNOSED DIABETICSThe Lancet, 1971